17/08/2022 - General information
A joint research project from the Hospital del Mar Medical Research Institute and the CNIC has been selected to receive a grant from the Carlos III Health Institute to analyse whether a greater presence of omega-3 in the blood is associated with a brain that is more resistant to this neurodegenerative disease. The research project led by Dr. Aleix Sala-Vila, from the Cardiovascular Risk and Nutrition Research Group at IMIM-Hospital del Mar has received one of the research, development and innovation project grants from the Carlos III Health Institute. The study will be carried out in conjunction with the National Centre for Cardiovascular Research Carlos III (CNIC) as part of the PESA study that this institute is developing with Banco Santander. The initiative will receive 114,000 euros in funding.
Més informació "Research into whether a diet rich in omega-3 helps prevent Alzheimer's disease"
28/06/2022 - General information
This is a study on the impact of the COVID-19 pandemic on the breast cancer screening program. Its main author is Dr. Guillem Bosch, resident physician of the PSMAR-UPF-ASPB Teaching Unit and member of the Health Services Research Group of the Hospital del Mar Medical Research Institute.
14/06/2022 - General information
It is published by Triacastela Publishing House. In it, Dr. Porta explains, in an easy and entertaining way, current epidemiological and public health issues, such as the management by governments of the COVID-19 pandemic. Epidemiology and epidemiologists have been in vogue over the last two years, when SARS-CoV-2 and COVID-19 have made all the headlines. A medical and scientific discipline that studies and acts on populations and groups of people under real conditions, which is carried out outside laboratories.
Més informació "Epidemiología cercana, the new book by Dr. Miquel Porta"
28/04/2022 - Press release
The study was carried out jointly by Germans Trias Hospital and the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar). The research team compared blood samples from 58 cases of patients hospitalised for heart attack complicated by primary ventricular fibrillation with those of 116 people who did not suffer this complication. A team of researchers from Germans Trias Hospital, the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the CIBER on cardiovascular diseases has demonstrated that regular consumption of foods rich in linoleic acid can help to reduce the risk of cardiac arrest due to ventricular fibrillation during the acute phase of a heart attack. The results of the study have been published in the journal Scientific Reports.
21/04/2022 - General information
The research project PROMES-U has been launched with the goal of enhancing the mental health of university students through the exploration of factors influencing the onset of mental health issues. Additionally, the project aims to implement and evaluate online interventions for promoting mental well-being and preventing problems related to depression and anxiety. The study is led by the Hospital del Mar Medical Research Institute (IMIM) and involves participation from UPF, the University of the Balearic Islands, Jaume I University of Castellón, Miguel Hernández University of Elche, and the University of Zaragoza.
Més informació "PROMES-U Study Initiated to Promote Student Mental Health"
25/01/2022 - General information
A study by CiSAL and CIBERESP shows that, once they have returned to work, they work at a lower rate than those who have not suffered from the disease. Men and women who had no sick leave or who were on sick leave for other illnesses were at least 9% more likely to continue working compared to workers who took cancer-related sick leave, according to this study carried out in Catalonia and published in 'Scientific Reports'. Not being able to work when you can and want to leads to a loss of self-esteem and social relationships, which can make recovering from cancer psychologically difficult", explains Fernando G. Benavides, the coordinator of the study.
21/01/2022 - Covid-19
12% of patients admitted for COVID-19 who also suffer heart damage need to be readmitted or die within the first year after recovering from the disease. In contrast, this occurs in only 1% of those who do not suffer heart damage during the SARS-CoV-2 infection, according to a study published in the Journal of Clinical Medicine. These people have a baseline situation that is aggravated by previous pathologies such as high blood pressure, chronic renal failure and episodes of heart failure. The authors of the study recommend routine screening for heart damage markers in the blood of patients admitted for COVID-19 to be able to carefully monitor these problems in the long term. Patients who suffer heart damage during a COVID-19 infection are more likely to need to be readmitted to hospital or to die than those who survive the disease without suffering this. This has been revealed by a study led by researchers from Hospital del Mar, the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the CIBER in Cardiovascular Diseases (CIBERCV), which has been published in the Journal of Clinical Medicine.
Més informació "Cardiac damage in COVID-19 patients is an indicator of poor long-term prognosis"
11/01/2022 - General information
The Government Delegation for the National Plan on Drugs has awarded the White Cross of the Order of Merit to Dr. Antònia Domingo-Salvany, who was the coordinator of the Epidemiology of Drugs of Abuse Research Group at the IMIM until 2017. This is public recognition and thanks for the work she has accomplished over a career spanning almost 30 years in the field of substance use epidemiology. Dr. Domingo has made a major contribution to our understanding of the extent and impact of drug use in the population, including aspects related to violence and illegal drug market activities, and has collaborated in the implementation of appropriate health initiatives. With her group, she has conducted studies to assess the magnitude of drug use in the population, contributing to the knowledge of its consequences, including psychiatric comorbidities, the presence of blood-borne infections, and quality of life-related health impairment. She has also been involved in studies that sought to evaluate tools for detecting substance use disorders in various settings, as well as potential associated psychiatric problems.
20/12/2021 - General information
The urgent need to find treatments for a large number of degenerative diseases has led a group of experts to develop a guide designed to accelerate new drug discoveries for neurological and psychiatric diseases. Project leads are Dr. Silvia Zaragoza Domingo, consultant and founder of Neuropsynchro, Barcelona, serving as coordinator collaborating with Drs. Jordi Alonso and Montserrat Ferrer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) and CIBERESP, and Dr. Manuel de Gracia, Facultat de Psicologia of Universitat de Girona (UdG). This guide was presented during the 34th Congress of the European Clinical Neurosychopharmacological College (ECNP) in Lisbon on 2-5 October and has been the group's priority project since it was established in 2018.
18/11/2021 - Press release
A study by researchers from Hospital del Mar, the Hospital del Mar Medical Research Institute and Hospital Son Espases, shows that the combination of a new antibiotic, ceftazidime/avibactam, with other antibiotics, can treat infections caused by variants of Pseudonomas aeruginosa that are resistant to all existing treatments. The study, published in Microbiology Spectrum, involved an in vitro analysis of the efficacy of the different treatments and their combinations to determine their effectiveness against variants of this bacterium, which is resistant to all existing drugs. Resistance to antibiotics has been identified by the World Health Organisation as one of the main threats to global health. Infection with Pseudomonas aeruginosa can cause pneumonia, heart problems and sepsis, especially in immunocompromised people
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
